Q32 Bio Inc. (QTTB)
Q32 Bio Inc. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
Q32 Bio Inc. (QTTB) is a Biotechnology company based in US with a market capitalization of $137.6M. Free cash flow was negative at -$33.5M. This page tracks QTTB's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
US · 28 employees · IPO Mar 28, 2018
Valuation
Valuation & price
$6.30as of May 17, 2026· -55.4% vs 52w high
2.6
P/E ratio
Latest-FY diluted EPS
3.28
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$137.6M
Market cap
—
Revenue growth (YoY)
99.3%
Gross margin
-$33.5M
Free cash flow (USD)
-$33M
Net debt
Net cash position
0.8%
Share dilution
1/5
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2016 → 2025
Free cash flow by year
2016 → 2025
Gross margin by year
2021 → 2025
Value screen
Graham defensive-investor tests
2
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last report: 10-Q filed May 5, 2026
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
- FinancingJun 25, 2026Filing
Securities Registration
- 8-K eventJun 16, 2026Filing
Annual Meeting Results
- Insider buyJun 1, 2026Filing
Insider Buy $15.0MORBIMED ADVISORS LLC · Director, 10% Owner · $15M
- Insider buyJun 1, 2026Filing
Insider Buy $15.0MXu Diyong · Director, 10% Owner · $15M
- 8-K eventMay 27, 2026Filing
Securities Purchase Agreement
- 8-K eventMay 5, 2026Filing
Financial Results Released
- Quarterly reportMay 5, 2026Filing
10-Q Filed
- 8-K eventApr 24, 2026Filing
Additional Shares Offering
Questions
Frequently asked questions
What is Q32 Bio Inc.'s market cap?
Q32 Bio Inc. (QTTB) has a market capitalization of $137.6M.
What is QTTB's P/E ratio?
QTTB trades at a price-to-earnings ratio of 2.6, based on its latest fiscal-year diluted earnings per share and the most recent cached price.
What is QTTB's price-to-book (P/B) ratio?
QTTB trades at 3.28 times book value per share.
Are insiders buying QTTB stock?
Yes — SEC Form 4 filings show 2 open-market insider buys and 0 sells at Q32 Bio Inc. in the last 90 days.
Same arena
Related companies in Biotechnology
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.